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Background: Determining the prerequisites for healthy aging is a major task in the modern world characterized by
a longer lifespan of the individuals. Besides lifestyle and environmental influences genetic factors are involved as
shown by several genome-wide association studies. Older individuals are known to have an impaired immune
response, a condition recently termed “inflamm-aging”. We hypothesize that the induction of this condition in the
elderly is influenced by the sensitivity of the innate immune system. Therefore, we investigated genetic variants of
the Toll-like receptor (TLR) family, one of the major family of innate immune receptors, for association with age in
two cohorts of healthy, disease-free subjects.
Results: According to sex we found a positive association of loss-of-function variants of TLR-1 and −6 with healthy
aging with odds ratios of 1.54 in males for TLR-6 (249 S/S), and 1.41, 1.66, and 1.64 in females for TLR-1 prom., TLR-1
(248 S/S), and TLR-1 (602 S/S), respectively. Thus, the presence of these variants increases the probability of
achieving healthy old age and indicates that a reduced TLR activity may be beneficial in the elderly.
Conclusions: This is the first report showing an association of TLR variants with age. While a loss of function of an
important immune receptor may be a risk factor for acute infections as has been shown previously, in the setting
of healthy ageing it appears to be protective, which may relate to “inflamm-aging”. These first results should be
reproduced in larger trials to confirm this hypothesis.
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The immune system of the elderly is characterized by
diminished effectiveness called immunosenescence. The
mechanism for a decreased immune response in the
elderly is complex and affects the innate as well as the
adaptive immune system. Decreased diversity of the
antigen repertoire resulting in diminished T- and B-cell
responses, and accumulation of functionally impaired
memory lymphocytes i.e. have been described to impair
the adaptive immunity of the elderly [1]. Furthermore, a
high-risk phenotype characterized by high CD8 and low
CD4 cell numbers, has been suggested to be associated
with higher mortality rate in a group of very old Swedish
subjects [2].* Correspondence: lutz.hamann@charite.de
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tem may also be affected in older age: Key functions of
neutrophils, macrophages, dendritic cells, and NK cells,
e.g. chemotaxis, phagocytosis, migration, and cytotoxicity
are known to be reduced in the elderly [3, 4]. One family
of “Pattern recognition receptors (PRRs)” important for
initiating the innate immune responses are the toll-like re-
ceptors (TLRs) recognizing “pathogen associated molecu-
lar patterns (PAMPs)” followed by the activation of the
innate immune response [5]. Age-associated dysfunctions
of human TLRs have been described before: An age
dependent decrease in TLR-1/2 heterodimer function
determined by a lessened TNF-α- and IL-6-release upon
stimulation as well as an overall decrease in cellular
TLR-1 expression have been described for monocytes of
the elderly [6]. A much broader decrease in TLR func-
tion also including the intracellular RNA-sensors TLR-7
and −8 has been observed for dendritic cells (DCs) from
aged subjects [7]. Single nucleotide polymorphismsarticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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TLRs therefore have been suspected to be associated
with age. However, only a few studies focusing on TLR
SNPs and aging are available today with conflicting
results: A functional TLR-4 SNP has been shown to be
overrepresented in centenarians and was suggested to
be associated with a longer lifespan [8]. However this
result could not be confirmed by a subsequent study [9].
Another important feature of immunosenescence is a
chronic low-grade inflammation of the elderly, also
termed “inflamm-aging”, characterized by increased
plasma levels of inflammatory cytokines, acute phase
proteins, and coagulation factors [10]. Most age-related
diseases such as atherosclerosis, cardiovascular diseases,
type 2 diabetes, and metabolic syndrome, representing
the leading causes of death in the elderly of the Western
world are characterized by chronic inflammation. There-
fore, inflamm-aging could be seen as the common
mechanism responsible for a general decline of health,
and an onset of chronic inflammatory diseases in the
elderly. The initiation of inflamm-aging is multifactorial
and not completely understood today. However, it results
in senescent cells exhibiting the so called “senescence as-
sociated secretory phenotype (SASP)” characterized by an
increased release of pro-inflammatory cytokines [10]. One
potential reason for inflamm-aging could be an increased
“translocation” of bacteria from the gut as has been shown
i.e. for HIV-infected subjects due to systemic immune ac-
tivation, which is also an attribute of the elderly [11]. An
increase of intestinal permeability with age has been
shown in an animal model but could not be conclusively
confirmed in humans [12, 13]. However, serum concentra-
tions of lipopolysaccharide binding protein (LBP), a surro-
gate marker for microbial translocation, increase with age
[14, 15]. Also the decline in adaptive immune functions
could result in a higher bacterial load due to latent
infections.
More recently it has been shown that an increased
DNA damage response in the elderly also triggers the
SASP phenotype [16]. Furthermore, free DNA or other
cellular breakdown products recently also termed
“danger-associated molecular patterns (DAMPS)” can
also stimulate the release of pro-inflammatory cytokines
by the innate immune system. Therefore, not only an
increased bacterial load but also of cellular breakdown
products increasing with age could affect the innate im-
mune response and participate in the low-grade chronic
inflammation of the elderly.
As described above various mechanisms are suspected
to result in inflamm-aging, one of them might be a
chronic inflammatory stimulus by PAMPs in response to
microbial translocation or by DAMPs generated by
cellular breakdown products. We hypothesize, that toler-
ance induction by these stimulatory compounds couldtake place in the elderly, which might explain in part the
decreased inflammatory response of these individuals. If
this is the case, loss of function SNPs within TLR genes
decreasing the overall sensitivity of the innate immune
system may increase the threshold level for tolerance
induction and thereby protect from inflamm-aging. In
addition, a decreased sensitivity of the innate immune
system might also be beneficial in terms of chronic
diseases. We have recently shown that loss of function
genotypes of TLR-1 (I602S) and TLR-6 (P249S) are pro-
tective in chronic inflammatory disease such as gastric
cancer and atherosclerosis [17, 18]. Although particu-
larly for several types of cancer current data are conflict-
ing [19] we speculate that these SNPs would be
beneficial for healthy aging and should be associated
with age in a healthy population. To test this hypothesis,
we genotyped two cohorts of healthy volunteers, one
from Germany and one from Lithuania, for 5 SNPs
within the TLR1/6/10 cluster. We show here for the first
time an age-dependent distribution for all of these SNPs
indicating the less functional homozygote genotypes to
be beneficial for healthy aging.
Results
The TLR-6/1/10 region and investigated SNPs
Several SNPs within the TLR-6/1/10 genes located in
close proximity to each other have been investigated in
case/control studies before [20–25]. We focus here on 5
functionally relevant SNPs that have been extensively
analyzed in vitro. Most detailed analyses were carried
out for TLR-1 (I602S) indicating that the presence of
this SNP inhibits the transport of the receptor to the cell
surface resulting in a complete loss of function. TLR-1
(A248S) and TLR-6 (P249S) have been shown to reduce
ligand-induced immune responses [26, 27]. The TLR-1
variant rs5743351 leads to a change of sequence within
the promoter region and has been suggested to influence
transcription leading to a change in cellular TLR-1 ex-
pression. The localizations of these SNPs and adjacent
genes that may harbour SNPs potentially being in link-
age disequilibrium are shown in Fig. 1.
TLR-6/1/10 SNPs are associated with age
To analyze whether these SNPs are associated with age
we genotyped two cohorts of healthy volunteers from
Germany and Lithuania. Baseline characteristic of geno-
typed subjects are shown in Table 1 and more detailed
information is presented in the Materials and Methods
section. Results of genotyping for both cohorts indicate
an unequal frequency distribution for TLR-1 and −6
SNPs in the German and for TLR-1 and −10 SNPs in
the Lithuanian cohort with P-values ranging from 0.04
to <0.001 comparing young and old subjects (Table 2).
The cut-off was set at age 50 because the onset of
Fig. 1 TLR-6/1/10 region on chromosome 4. Arrangement of TLR-6/1/10 and adjacent genes on chromosome 4 and the localization of
investigated SNPs
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Since sex is the most accepted factor associated with
successful aging, with females reaching significantly
higher age, we stratified our groups for sex. Func-
tional studies for TLR-1 I602S and TLR-6 P249S
suggested the homozygous mutated genotypes to be
non or less functional regarding the initiated im-
mune response, respectively. Therefore, we applied a
recessive model to analyze association with age comparing
homozygous mutated subjects with combined “wild-type”
and heterozygous subjects. First we employed linear re-
gression to show an association of the different genotypes
with age over the whole range from age 25 to age 85.
Analyzing the association of less or non-functional
homozygote genotypes with age by linear regression re-
veals significant associations for TLR-1 prom.: P = 0.039,
TLR-1 (N248 S): P = 0.036, and TLR-1 (I602S): P = 0.014
in males and TLR-1 (I602S): P = 0.015 in females within
the German cohort (Table 3). For the Lithuanian cohort
we found significant associations only for females: TLR-1
prom.: P = 0.003, TLR-1 (N248S): P = 0.003, and TLR-1
(I602S): P = 0.032, and TLR-10 (V775L): P = 0.007
(Table 3). Combination of both groups yielded signifi-
cant associations for TLR-6 in males and TLR-1 prom.,
TLR-1 (N248S), TLR-1 (I602S) and TLR-10 (V775L) in
females, P = 0.002, P = 0.005, P = 0.001, P = 0.032, and
P = 0.032, respectively. Of note, significant associations
for TLR-1 and 6 are accompanied with positive β-Table 1 Basline characteristics of study subjects
German cohort
All Age < 50 Age
N = 1388 N = 865 N = 5
Mean age 43.3 30.09 65
SD 18.8 7.3 8
Age range 19–49 50–8
Male/female 768/620 394/471 374/values. Significant associations of TLR-10 show nega-
tive β-values, indicating less functional genotypes for
TLR-1 and −6 being overrepresented in the healthy
elderly whereas the less functional TLR-10 genotype is
underrepresented, which might be explained by the re-
cent finding that TLR-10 in contrast to TLR-1 and 6 is
an anti-inflammatory receptor [28]. However, the r2-
values are rather low (0.001–0.021) indicating weak as-
sociations of these genotypes with age. We compared
the correlation between all TLR-1 variants and found
the correlation coefficients to be >0.875, P = 0.001 (data not
shown) suggesting that the three TLR-1 SNPs are in strong
linkage disequilibrium.
Homozygous loss-of-function genotypes are more frequent
in the Elderly
The rather low r2-values obtained by linear regression
analysis may be explained by the mechanisms of action
of these SNPs. Given that these SNPs may influence the
onset of common diseases associated with age or the de-
velopment of inflamm-aging we speculate that an associ-
ation with age would be more visible comparing older
subjects with younger subjects, than analyzing age asso-
ciation over the whole range by linear regression ana-
lysis. Since the onset of age-related diseases is around
the age of 50, we divided both cohorts in young subjects
(age < 50 years) and old subjects (age ≥ 50 years) and
assessed the probability of achieving the old subjectsLithuanian cohort
≥ 50 All Age < 50 Age≥ 50
23 N = 1028 N = 772 N = 256
.43 42.6 37.4 58.4
.3 11.7 7.2 7.7
1 25–49 50–84
149 631/397 516/256 115/141
Table 2 Genotype distribution in the German and Lithuanian cohort
German cohort Young subjects (Age < 50, n = 866) Old subjects (Age≥ 50, n = 523) P-value
Wt (%) Het (%) Hom (%) Wt (%) Het (%) Hom (%)
TLR-6 (P249S)a 336
(38.8)
399
(46.1)
130
(24.9)
158
(30.2)
256
(48.9)
109
(20.8)
0.001
TLR-1 70 300 495 15 184 324 <0.001
prom. (8.1) (34.6) (57.2) (2.9) (35.2) (62.0)
TLR-1 68 303 494 15 173 335 <0.001
(N248S) (7.9) (35.0) (57.0) (2.9) (33.1) (64.1)
TLR-1 91 329 445 21 186 316 <0.001
(I602S) (10.5) (38.0) (52.4) (4.0) (35.6) (60.4)
TLR-10 603 231 31 371 142 10 0.205
(V775L) (69.6) (26.7) (3.6) (70.9) (27.2) (1.9)
Lithuanian cohort Young subjects (Age < 50) Old subjects (Age≥ 50) P-value
Wt (%) Het (%) Hom (%) Wt (%) Het (%) Hom (%)
TLR-6 (P249S) 319 336 106 97 114 38 0.689
(n = 761, n = 250) (41.9) (44.2) (13.9) (38.8) (45.6) (15.2)
TLR-1 prom. 25 222 515 4 52 194 0.009
(n = 762, n = 250) (3.3) (29.1) (67.6) (1.6) (20.8) (77.6)
TLR-1 (N248S) 24 220 525 3 52 198 0.008
(n = 769, n = 251) (3.1) (28.6) (68.3) (1.2) (20.7) (78.9)
TLR-1 (I602S) 29 242 498 7 58 189 0.018
(n = 762, n = 250 (3.8) (31.8) (65.4) (2.8) (23.2) (75.6)
TLR-10 (V775L) 575 166 7 209 38 1 0.044
(n = 748, n = 248) (76.9) (22.2) (0.9) (84.3) (15.3) (0.4)
P-values were determined by 3×2 Chi2 comparing young and old subjects. Significant P-values below 0.05 were printed in bold. Different sample numbers in the Lithuanian
cohort are due to the fact that some samples failed to be genotyped for all SNPs.aTLR-6 genotypes for this cohort have mostly been published previously [17]
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genotype-distribution as predictor variable by univariate
logistic regression analysis (Table 4). Univariate analysis
yielded significant associations for TLR-1 (248S/S) and
TLR-1 (602S/S) in the German cohort for males with
the following Odds ratios (OR): 1.36 (95 % CI: 1.02–1.81)
P-value: P = 0.038 and OR: 1.41 (95 % CI: 1.06–1.87), P =
0.02, respectively. For females we found only TLR-1
(602S/S) to be significantly associated, OR: 1.53 (95 % CI:
1.05–2.23) P = 0.027, (Table 4). Significant associations for
the Lithuanian cohort were as follows: Males: TLR-1
(602S/S), OR: 1.77 (95 % CI: 1.09–2.86), P-value: 0.02 and
for females: TLR-1 prom, TLR-1 (248S/S), TLR-1 (602S/S)
and TLR-10 (775 V/V) with OR: 1.44 (95 % CI: 1.13–
1.83); P = 0.003, OR: 2.12 (95 % CI: 1.30–3.43), P = 0.002,
OR: 1.62 (95 % CI:1.04–2.53); P = 0.033 and OR: 0.52
(0.31–0.89), P = 0.016, respectively.
The combination of both cohorts yielded significant asso-
ciations for TLR-6 in males and for all TLR-1 and TLR-10
variants in females (Table 4); for TLR-6 (249S/S) in males
OR: 1.54 (95 % CI: 1.15–2.05) P-value 0.003, in females for
TLR-1 prom., 248S/S, and 602S/S OR: 1.41 (95 % CI: 1.06–
1.89) P= 0.018, OR: 1.66 (95 % CI: 1.24–2.23) P= 0.001 andOR 1.64 (95 % CI: 1.28–2.19) P= 0.001, respectively. The
TLR-10 variant 775 V/V showed a borderline significant as-
sociation OR 0.73 (95 % CI: 0.54–1.01) P= 0.05. Again, as
shown by linear regression analysis significant associations
for TLR-10 are accompanied by OR’s below 1, whereas sig-
nificant associations for TLR-1 and 6 are accompanied by
OR’s over 1. For the combined analysis we performed a
power analysis showing the power to be >82 % for all signifi-
cant associations with the exception of the borderline associ-
ation of TLR-10 with a power of 50 %.
In order to determine which age group shows the stron-
gest increase of the homozygous less functional genotypes
we compared the genotype distribution in young subjects
(19–45 years, male: n= 910, female: n= 727) with subjects
of 50–64 years (male: n = 281, female: n = 176), 65–
74 years (male: n = 148, female: n = 70), and 75–85
years (male: n = 60, female: n = 40), respectively. This ana-
lysis was employed for the combined cohort only since
separate analyses of the two cohorts would lead to low
sample numbers of the subgroups. As shown in Table 5
comparison of young subjects with subjects of 50–64
years yielded nearly the same significant associations
with comparable P-values and slightly enhanced ORs.
Table 4 Homozygous less functional genotypes are increased in older subjects
Male Female
German Odds ratio (95 % CI) P-value Odds ratio (95 % CI) P-value
TLR-6 (249S/S) 1.41 (0.98–2.04) 0.067 1.56 (0.97–2.50) 0.066
TLR-1 prom. 1.31 (0.98–1.76) 0.065 1.02 (0.70–1.48) 0.93
TLR-1 (248S/S) 1.36 (1.02–1.81) 0.038 1.31 (0.90-1.92) 0.17
TLR-1 (602S/S) 1.41 (1.06–1.87) 0.02 1.53 (1.05–2.23) 0.027
TLR-10 (775 V/V) 1.05 (0.77–1.44) 0.741 1.01 (0.69–1.54) 0.89
Lithuanian
TLR-6 (249S/S) 1.53 (0.89–2.62) 0.123 0.88 (0.65–1.89) 0.394
TLR-1 prom. 1.46 (0.91–2.36) 0.117 1.44 (1.13–1.83) 0.003
TLR-1 (248S/S) 1.42 (0.88–2.83) 0.152 2.12 (1.30–3.43) 0.002
TLR-1 (602S/S) 1.77 (1.09–2.86) 0.02 1.62 (1.04–2.53) 0.033
TLR-10 (775 V/V) 0.13 (0.36–1.14) 0.132 0.52 (0.31–0.89) 0.016
Combined
TLR-6 (249S/S) 1.54 (1.15–2.05) 0.003 1.16 (0.79–1.68) 0.44
TLR-1 prom. 1.12 (0.89–1.41) 0.34 1.41 (1.06–1.89) 0.018
TLR-1 (248S/S) 1.13 (0.89–1.42) 0.32 1.66 (1.24–2.23) 0.001
TLR-1 (602S/S) 1.18 (0.94–1.48) 0.15 1.64 (1.28–2.19) 0.001
TLR-10 (775 V/V) 0.97 (0.75–1.25) 0.79 0.73 (0.54–1.01) 0.05
Analysis was carried out by univariate logistic regression comparing the less functional homozygote genotype with the others in young versus old subjects. The
reference were young subjects and the wild type + heterozygous genotype. Significant P-values below 0.05 were printed in bold
Table 3 Associations of less functional TLR-1/6/10 genotypes with age
Predictor German cohort Male Female
β S.E R2 P 95 % CI β S.E R2 P 95 % CI
TLR6 (249S/S) −0.69 0.75 0.001 0.122 −2.17–0.78 −1.20 0.77 0.002 0.355 −2.71–0.32
TLR-1 prom 2.24 1.13 0.004 0.039 0.12–4.56 0.81 1.12 0.001 0.470 −1.39–3.01
TLR-1 (248 S/S) 2.38 1.13 0.004 0.036 0.80–4.05 2.02 1.13 0.004 0.074 0.80–4.05
TLR-1 (602 S/S) 2.68 1.05 0.007 0.014 0.55–4.82 2.57 1.09 0.008 0.015 0.51–4.63
TLR-10 (775 V/V) −0.39 1.28 0.001 0.760 −2.89–2.11 −0.39 1.33 0.001 0.770 −3.00–2.22
Lithuanian cohort
TLR6 (249S/S) 0.97 0.61 0.002 0.112 −0.23–2.16 −0.97 0.91 0.001 0.288 −2.77–0.83
TLR-1 prom 1.11 0.82 0.001 0.178 −0.51–2.72 3.41 1.15 0.020 0.003 1.15–5.67
TLR-1 (248 S/S) 1.08 0.82 0.001 0.189 −0.53–2.66 3.56 1.17 0.021 0.003 1.26–5.86
TLR-1 (602 S/S) 1.33 0.79 0.003 0.093 −0.22–2.87 2.36 1.10 0.009 0.032 0.20–4.51
TLR-10 (775 V/V) −1.10 0.96 0.001 0.254 −2.99–0.79 −4.13 1.53 0.016 0.007 −7.12–1.13
Combined
TLR6 (249S/S) 1.88 0.61 0.006 0.002 0.70–3.07 0.74 0.74 0.001 0.310 −0.70–2.19
TLR-1 prom 1.05 0.76 0.001 0.170 −0.45–2.54 2.40 0.85 0.007 0.005 0.74–4.06
TLR-1(248 S/S 1.03 0.76 0.001 0.176 −0.46–2.52 3.24 0.85 0.013 0.001 1.56–4.91
TLR-1 (602 S/S) 1.21 0.73 0.001 0.096 −0.22–2.64 3.24 0.80 0.015 0.032 1.68–4.80
TLR-10 (775 V/V) 0.21 0.87 0.001 0.813 −1.50–1.19 −2.25 1.05 0.004 0.032 −4.30–0.20
Analysis was carried out by univariate linear regression. Significant P-values below 0.05 were printed in bold
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Table 5 Homozygous less functional genotypes are especially increased in 50–64 years old subjects
Combined cohort Male Female
TLR-6 (249 S/S) Odds ratio (95 % CI) P-value Odds ratio (95 % CI) P-value
50–64 years 1.52 (1.07–2.15) 0.019 1.51 (0.99–2.30) 0.056
65–74 years 1.47 (0.94–2.29) 0.093 0.55 (0.23–1.29) 0.170
75–85 years 1.83 (0.98–3.43) 0.059 0.91 (0.37–2.20) 0.827
TLR-1 prom.
50–64 years 1.17 (0.88–1.56) 0.271 1.79 (1.24–2.57) 0.002
65–74 years 1.03 (0.71–1.48) 0.889 1.11 (0.66–1.85) 0.697
75–85 years 1.11 (0.64–1.93) 0.707 0.90 (0.49–1.67) 0.742
TLR-1 (248S/S)
50–64 years 1.22 (0.91–1.62) 0.180 1.85 (1.28–2.66) 0.001
65–74 years 1.01 (0.70–1.46) 0.946 1.49 (0.87–2.54) 0.149
75–85 years 1.02 (0.59–1.76) 0.947 1.31 (0.69–2.49) 0.407
TLR-1 (602S/S)
50–64 years 1.33 (1.00–1.76) 0.047 1.76 (1.25–2.50) 0.001
65–74 years 1.09 (0.76–1.56) 0.647 1.50 (0.90–2.49) 0.122
75–85 years 0.87 (0.51–1.47) 0.591 1.45 (0.77–2.73) 0.245
TLR-10 (775 V/V)
50–64 years 0.99 (0.73–1.36) 0.971 0.69 (0.46–1.01) 0.057
65–74 years 1.12 (0.76–1.669 0.569 0.65 (0.36–1.17) 0.149
75–85 years 1.01 (0.55–1.85) 0.98 1.11 (0.58–2.13) 0.763
Analysis was carried out by univariate logistic regression comparing the less functional homozygote genotype with the others in different age groups. The reference
were 19–49 years old subjects (male: n = 910, female: n = 727) and the wild type + heterozygous genotype. Significant P-values below 0.05 were printed in bold
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cant associations most likely due to low sample num-
bers in these groups. However, the decreased OR’s in
these groups compared to the group of 50–64 years
may indicate that these associations are not present
in older subjects.Discussion
We show here for the first time an association of SNPs
within the TLR-6/1/10 cluster and age. The less functional
genotypes of TLR-1 and −6 are positively associated with
age as indicated by positive β-values (linear regression,
Table 3) or OR’s above 1 (logistic regression, Table 4). In
contrast, the mutated TLR-10 genotype shows a negative
association with age as indicated by negative β values or
OR’s below 1. This could be explained by the recent finding
that TLR-10, in contrast to TLR-1 and 6, is viewed as an
anti-inflammatory receptor [28]. Although the results differ
slightly between the two study groups potentially due to
ethnic variations, we conclude that these genotypes may be
beneficial in terms of healthy aging. Analyzing the com-
bined cohort for different age groups showed that these re-
sults are most prominent in subjects of 50–64 years
compare to young subjects of 19–49 years (logistic regres-
sion, Table 5).Differences in life span have been attributed to various
factors including lifestyle, environmental factors, sex, and
genetics, which may account for life span determination
of about 30 % [29]. Several genome-wide association stud-
ies have been carried out to identify polymorphisms asso-
ciated with longevity. Associations have been found that
were confirmed by several studies, e.g. variants within the
CETP-, APOC-3-, and ADIPOQ-genes [30, 31]. An asso-
ciation of the TLR-6/1/10 region has never been reported
by these GWAS. However, in this study we aimed to in-
vestigate the genetics of a healthy life-span, which is
clearly different from longevity. It has been shown that
lack of risk alleles for age-associated common diseases are
not necessarily associated with longevity [32, 33]. We
therefore compared a healthy middle-aged control group
younger than 50 years with a healthy group of aged sub-
jects with an age ranging from 50 to 80 years. We set the
cut-off at age 50 because it is assumed that in modern de-
veloped countries mortality due to age-related diseases be-
fore the age of 50 is minimal. Therefore, in contrast to our
older group of healthy subjects the control group is a
nearly unselected group regarding age-related morbidity.
Age of 50+ years is characterized by the onset of com-
mon age-associated diseases and inflamm-aging [34]. In
line, the increase of serum levels of LBP, an acute-phase
marker starts at an age of 50 in healthy subjects, which
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sponse [14]. It has been speculated that a sensitive im-
mune system, which is clearly beneficial during young
age may be harmful for the elderly [34]. This point of
view fits well to the mechanism of antagonistic plei-
otropy suggested to be involved in age-dependent dis-
eases and longevity [30]. Our finding of less functional
TLR-6/1/10 genotypes being over-represented in the
healthy elderly further supports this view of aging. An
earlier study failed to find an association of two TLR-1
SNPs (N248S, I602S) with age, however, in this study
nonagenarians were compared with old controls (66–89
years) [35], which is a different approach as compared to
the one used here. Our study suggests that the beneficial
effects of the less functional genotypes is most promin-
ent at the age of 50–64 years. This period of life span is
the time of onset of age related diseases which are in
part characterized by chronic inflammation, indicating
that these variants maybe involved in this inflammatory
process.
The mutated allele of an intergenic SNP between
TLR-1 and −6 has been shown to be associated with al-
lergic sensitization [36]. This SNP exhibits a similar dis-
tribution in Africa and Europe as found for the TLR-1
SNPs we investigated suggesting a strong linkage. In line,
an earlier study investigating several SNPs within TLR-1
and −6 (P249S) showed that they are associated with an
increased risk for childhood asthma [37]. These results,
taken together with the results presented here, also fit to
the theory of antagonistic pleiotropy.
A mechanism explaining this could be the develop-
ment of immune-tolerance in the elderly by increased
immune stimuli in aged people by microbial transloca-
tion or cellular breakdown products [38]. Tolerance has
been described first as endotoxin (LPS)-induced toler-
ance where exposure of immune cells with low concen-
trations of LPS results in a refractory state towards a
secondary stimulation [39]. More recently it has been
shown that cross-tolerance also could be induced by
stimulation with low concentrations of TLR2/1 agonists
resulting in tolerance against a second stimulation with
LPS [40]. Development of immune-tolerance depends
on the detection of minute amounts of bacterial or dan-
ger associated stimuli. Variants that affect the sensitivity
of the innate immune system should influence this
process. Furthermore, variants that lower the sensitivity
of the innate immune system could also be beneficial in
terms of age associated chronic inflammatory diseases.
However, this has to be investigated and proven in fur-
ther studies.
Another interesting feature of TLR6/1/10 SNPs is the
high variation in allelic frequencies observed among
different ethnia: In African populations the TLR-1 ”wt”-
alleles account for nearly 90 %, whereas in Europe the“mutated” allele has a frequency of around 75 %. This
difference could be connected to antagonistic pleiotro-
phy since evolutionary pressure should be quite different
due to different infectious diseases, lifestyle and environ-
mental factors within the different continents. Other
explanations for beneficial effects of less functional
TLR6/1/10 genotypes might be a possible linkage with
SNPs within genes nearby, for example Mir-574 located
adjacent to TLR-6. Mir-574 has been associated with
outcome of sepsis and may therefore be an important
regulator of the immune responses [41]. Of note, it has
been shown recently that TLR-1 and −6 less functional
genotypes are associated with an enhanced immune re-
sponse after BCG vaccination [42] potentially indicating
a completely different mechanism by which these SNPs
could be involved in healthy aging.
Since our conclusions are speculative we will discuss
the limitations of our study in detail here: The advantage
of our study is that we have two ethnically different pop-
ulations with a sample size yielding sufficient statistical
power showing similar results. The limitation due to the
retrospective character of our study is the insufficient
characterization of the study subjects regarding con-
founding risk factors. Although all participants reported
to not have had a chronic disease or regularly use of
medication at recruitment time, in future studies these
important points may have to be controlled more
thoroughly and additional confounding risk factors e.g.
smoking, alcohol consume and others have to be
checked carefully in order to confirm our findings. How-
ever, in light of the current research on genetic determi-
nants of human health span we think that our results
present an important first link of the involvement of
TLR-6/1/10 polymorphisms in healthy ageing.
Conclusion
We present here first evidence for a positive association
of less functional TLR variants with increased age in
healthy subjects. This association is most prominent in
subjects of 50–64 years, suggesting these variants to be
involved in the onset of age related diseases. However,
this hypothesis needs to be confirmed by further studies.
Methods
Study subjects
German cohort
DNA from 900 healthy controls obtained from the
PopGen biobank (University of Kiel, Germany) and
from further 488 healthy controls collected at the In-
stitute of Microbiology, Charité University Medical
Center Berlin were included for the German cohort.
Participants reported to not have had a chronic disease
or regularly use medication at recruitment. All partici-
pants were of Caucasian ethnicity, the samples obtained
Hamann et al. Immunity & Ageing  (2015) 12:7 Page 8 of 9from PopGen biobank were from residents of Schleswig
Holstein, the northern part of Germany. PopGen biobank
represents a population-based cohort. This cohort has
been described previously showing an age-dependent
distribution of the TLR-6 P249S genotype [17]. Slightly
different sample numbers are due to the inclusion of
some additional subjects and the exclusion of some
samples that could not be analyzed for all SNPs under
investigation. The study procedures followed were in
accordance with the Helsinki Declaration of 1975, as re-
vised in 1983 and was approved by the Ethical Board of
the Charité - Universitätsmedizin Berlin and University
of Kiel, respectively, and written informed consent was
obtained from all participants. This study were ap-
proved by the local ethics committees.
Lithuanian cohort
Blood of 1028 healthy voluntary unrelated blood donors,
nearly representing the typical Lithuanian overall popula-
tion, was obtained during the years 2008–2012 at National
Blood Center (Kaunas, Lithuania). All participants were of
Caucasian ethnicity and were free of chronic disease or
permanent medication use. The study was approved by
Lithuanian Bioethics committee (Protocol No. 2/2008)
and all subjects have signed an informed consent form to
participate in the study. DNA from whole blood was ex-
tracted using salting-out method. This cohort has been
previously used for hemochromatosis gene HFE studies
[43]. All participants were of Caucasian origin and both
parents were born in Lithuania. This study were approved
by the local ethics committees, and carried out in accord-
ance with the ethical guidelines of the 1975 Declaration of
Helsinki.
Genotyping
Genomic DNA was prepared by standard procedures
from whole blood. Genotyping was carried out by PCR in-
cluding fluorescence-labeled hybridization FRET probes
followed by melting curve analysis employing the LightCy-
ler 480™ (Roche Diagnostics). Genotyping for TLR-6 SNP
P249S (rs5743810), TLR-1 A248S (rs4833095), TLR-1
I602S (rs5743618) was described previously [17, 44, 45].
Primer and probes were as follows: rs5743810: f-primer:
gaaagactctgaccaggcat, r-primer: ctagtttattcgctatccaagtg,
anchor probe: LC640-ttaccctcaaccacat agaaacgacttgga,
sensor probe: accagaggtccaaccttactgaa-FL; rs4833095: f-
primer: ttggatgtgtca gtcaagactgtag, r-primer: gcttcacgtttg
aaattgag, anchor probe: LC640-gtttgaagtttcgccagaatacttag
g, sensor probe: ttaaggtaagacttgataactttgg-FL; rs5743618:
f-primer: tgtgactacccggaaagttataga, r-primer: cccagaaagaa
tcgtgcc, anchor probe: LC640-cctccctctgcatctacttggat, sen-
sor probe: cca tgctggtgttggctgtgactgtg-FL.
TLR-1 prom (rs5743551): Melting curve analysis was
carried out employing following primers: f-primer:gcatatttttactgccctgaatc and r-primer: tggctcccaaaggc
attgac, anchor probe: LC640-actgccctgcccacttccct, and
sensor probe: ttcagagtgctgagaagcttccc-FL resulting in
melting points of 63 °C and 57 °C for the wild-type,
and the mutated allele, respectively.
TLR-10 V775L (rs4129009): Melting curve analysis
was carried out employing following primers: f-primer:
gagactcttcatttaactctgtga and r-primer: cccaaggataggcgtaa
, anchor probe: LC640-agccaccagagaaatgtatgaactgca, and
sensor probe: cttcgagctgctatta-atgttaatgtat-FL resulting
in melting points of 60 °C and 56 °C for the wild-type,
and the mutated allele, respectively. Primers and probes
were designed by O. Landt (TIB-MOLBIOL, Berlin,
Germany).
Statistics
Linear and logistic regression analyses have been per-
formed by employing the IBM SPSS Statistics software
package (version 20.0, IBM, Munich, Germany). Power
analysis was carried out online by the openepi webside
(http://www.openepi.com).
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